Sangamo BioSciences (SGMO) Reports Fourth Quarter and Full Year 2011 Financial Results

Lucas Energy (LEI) Announces Completion of Hagen Ranch No.4H Well

HOUSTON, Feb. 8, 2012 (GLOBE NEWSWIRE) — Lucas Energy, Inc. (NYSE Amex:LEI), an independent oil and gas company (the “Company” or “Lucas”), today announced that the Company has completed the Hagen Ranch No.4H well in Gonzales County, Texas as a flowing horizontal oil well in the Austin Chalk formation. The official 24 hour test that will be reported to the regulatory agency is 475 BOPD (barrels of oil per day, 232 MCFPD (thousands of cubic feet) of gas, and 103 BWPD (barrels of water per day – load water or drilling water, not formation water) with 419 psig (pounds per square inch) of FTP (flowing tubing pressure) on a 20/64″ choke. Lucas has approximately a 25% working interest in this well.

Further testing indicated that the well is capable of producing 846 BOPD, 422 MCFPD, and 264 BLWPD (load water) at 283 psig FTP on a 36/64″ choke. This choke size is slightly greater than a ½” pipe, or approximately 60% of the full opening choke size. Indications are that the Hagen Ranch No.4H well may have a greater capacity curing the initial production period. Future production rates will be determined by technical information, safety, tank capacity, and other factors. At some time in the future, the well may be put on artificial lift. Specifically a pumping unit may be added.

William A. Sawyer, President and Chief Executive Officer of the Company, said, “The drilling and completion of the Hagen Ranch No.4H well opens a new chapter in the company history book.” For more information on this and other activities of the Company, visit the Lucas Energy web site at www.lucasenergy.com.

Company Website: www.lucasenergy.com

Forward-Looking Statement

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Act”) and Section 21E of the Securities Act of 1934, as amended (the “Exchange Act”). In particular, the words “believes,” “expects,” “intends,” “plans,” “anticipates,” or “may,” and similar conditional expressions are intended to identify forward-looking statements and are subject to the safe harbor created by these Acts. Any statements made in this news release about an action, projection, event or development, are forward-looking statements. Such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be correct. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company. Statements regarding future drilling and production are subject to all of the risks and uncertainties normally incident to the exploration and development of oil and gas. These risks include, but are not limited to, completion risk, dry hole risk, price volatility, reserve estimation risk, regulatory risk, potential inability to secure oilfield service risk as well as general economic risks and uncertainties, as disclosed in the Company’s SEC filings including its Form 10-K and Form 10-Q’s. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. The forward-looking statements in this press release are made as of the date hereof. The Company takes no obligation to update or correct its own forward-looking statements, except as required by law, or those prepared by third parties that are not paid for by the Company. The Company’s SEC filings are available at http://www.sec.gov.

The Lucas Energy logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4192

CONTACT: Andrew Lai, CFO
         alai@lucasenergy.com
         (713) 528-1881

         Michael Brette J.D., Advisor
         mikebrette@gmail.com
         (951) 236-8473

RAM Energy Resources, Inc. (RAM) Announces Closing of $550 Million Recapitalization

NovaBay Pharmaceuticals (NBY) to Present at the 14th Annual BIO CEO & Investor Conference

EMERYVILLE, Calif., Feb. 8, 2012 (GLOBE NEWSWIRE) — NovaBay^® Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide^® compounds for the local non-systemic treatment and prevention of infections, today announced that Ron Najafi, Chief Executive Officer, will present at the 14^th Annual BIO CEO & Investor Conference in New York, NY, held February 13-14, 2011, at the Waldorf-Astoria Hotel.

Dr. Najafi and Tom Paulson, Chief Financial Officer, will be available to respond to questions and to participate in one-on-one meetings with investors attending the conference.

Event	14th Annual BIO CEO & Investor Conference
Date	Tuesday, February 14, 2012
Time	10:00am ET
Place	The Waldorf-Astoria Hotel (Duke of Windsor, 4th floor)

About NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals is a clinical-stage biotechnology company focused on developing its proprietary and patented Aganocide compounds. These are novel, synthetic anti-infectives with activity against bacteria, fungi and viruses, and are being developed to treat and prevent a wide range of local, non-systemic infections with a low likelihood of developing bacterial resistance.

NovaBay is focusing its technology on four distinct therapeutic areas: dermatology, ophthalmology, urology and hospital infections. In dermatology, the focus is on developing NVC-422 Gel formulation for the highly contagious skin infection, impetigo. NovaBay has the advantage of being partnered with Galderma, the leading dermatology company in the world. In ophthalmology, the goal is to develop an eye drop for viral conjunctivitis. In urology, NovaBay aims to reduce the incidence of urinary catheter blockage and encrustation (UCBE) and the associated urinary tract infections with an irrigation solution containing NVC-422. In hospital infections, NovaBay is targeting the six-million-patient market of chronic non-healing wounds, such as pressure, venous stasis and diabetic ulcers with its proprietary anti-infective solution, NeutroPhase®, the only pure hypochlorous acid solution which has received two 510(k) clearances from the Food and Drug Administration. For additional information, visit: www.novabaypharma.com.

CONTACT: Investors:
         NovaBay Pharmaceuticals, Inc.
         Thomas J. Paulson
         Chief Financial Officer
         510-899-8809
         tjpaulson@NovaBaypharma.com

         Investors and Media:
         The Ruth Group

         Joshua Drumm, PhD (Investors)
         (646) 536-7006
         jdrumm@theruthgroup.com

         Victoria Aguiar (Media)
         (646) 536-7013
         vaguiar@theruthgroup.com

Innodata (INOD) Reports Fourth Quarter and Fiscal Year 2011 Results

INNODATA ISOGEN, INC. (NASDAQ: INOD) today reported results for the fourth quarter and the 12 months ended December 31, 2011.

• Total revenue was a record $23.7 million in the fourth quarter of 2011, a sequential increase of 23% from $19.2 million in the third quarter of 2011, and a 59% increase from $14.9 million in the fourth quarter of 2010. The increase is primarily attributable to higher revenue from eBook-related services that the Company performs for one of its larger clients and to revenue from analytics services that the Company performs for a major accounting firm.
• Net income for the fourth quarter of 2011 was $2.3 million, or $0.09 per diluted share, compared to net income of $1.4 million, or $0.06 per diluted share, in the third quarter of 2011, and net income of $1.2 million, or $0.05 per diluted share, in the fourth quarter of 2010. The increase in net income is primarily attributable to higher revenue and to an increase in gross margins from 33% in the third quarter of 2011 and 22% in the fourth quarter of 2010 to 36% in the fourth quarter of 2011.
• For the 12 months ended December 31, 2011, total revenue was $73.9 million, a 20% increase from $61.5 million in 2010. Net earnings improved significantly, from a net loss of $0.7 million, or ($0.03) per diluted share, in 2010, to net earnings of $4.5 million, or $0.18 per diluted share, in 2011. The growth in net earnings is primarily attributable to higher revenue and to an increase in gross margins from 23% in 2010 to 32% in 2011.
• Cash and cash equivalents and short-term investments totaled $17.2 million as of December 31, 2011, a decline of $7.0 million from $24.2 million as of September 30, 2011. The reduction is primarily on account of an $8.8 million increase in accounts receivable from $12.9 million as of September 30, 2011 to $21.7 million as of December 31, 2011 and approximately $2.5 million in investments made during the quarter for establishing two new delivery centers in Asia, and continuing investment in the Company’s recently-launched Innodata Advanced Data Solutions (IADS) segment. A significant portion of the increase in accounts receivable as of December 31, 2011 was from one of our large customers because of a process delay.

“In 2011, we succeeded at growing revenue by 20% and turning a 2010 pre-tax loss of $1.2 million to 2011 pre-tax earnings of $5.3 million, all the while making an investment of $2.7 million in operating expenses and $2 million in capital expenditures in our IADS division,” stated Jack Abuhoff, the Company’s Chairman and CEO. “Our IADS investment has enabled us to build a platform and service capability to provide high quality advanced data analytics to healthcare, financial, and insurance sectors for risk management and related business operations. We expect that IADS will begin contributing to revenue during the first half of 2012.”

Abuhoff concluded, “Our business in 2012 is off to a good start. We’re anticipating revenue for the first quarter of 2012 to be approximately $21.0 million.”

Timing of Conference Call with Q&A

Innodata will conduct an earnings conference call, including a question and answer period, at 11:00 AM eastern time today. You can participate in this call by dialing the following call-in numbers:

The call-in numbers for the conference call are:

1-800-723-6575 (Domestic)

1-785-830-1997 (International)

1-888-203-1112 (Domestic Replay)

1-719-457-0820 (International Replay)

Pass code on both: 7914822

Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of www.innodata.com. Please note that the Webcast feature will be in listen-only mode.

Call-in or Webcast replay will be available for 30 days following the conference call.

Innodata (NASDAQ: INOD) is a leading provider of business process, technology and consulting services, as well as products and solutions, that help our valued clients create, manage, use and distribute digital information. Propelled by a culture of quality, service and innovation, we have developed a client base that includes many of the world’s preeminent media, publishing and information services companies, as well as leading enterprises in information-intensive industries such as aerospace, defense, financial services, government, healthcare, high technology, insurance, intelligence, manufacturing and law.

Recent honors include EContent Magazine’s EContent 100, KMWorld Magazine’s 100 Companies That Matter in Knowledge Management, the International Association of Outsourcing Professionals’ (IAOP) Global Outsourcing Top 100, D&B India’s Leading ITeS and BPO Companies and the Black Book of Outsourcing’s Top List of Leading Outsourcing Providers to the Printing and Publishing Business.

Headquartered in the New York metro area, Innodata has offices and operations in the United States, the United Kingdom, Israel, India, Sri Lanka, and the Philippines.

This release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The words “project,” “head start,” “believe,” “expect,” “should,” “anticipate,” “indicate,” “point to,” “forecast,” “likely”, “optimistic” and other similar expressions generally identify forward-looking statements, which speak only as of their dates.

These forward-looking statements are based largely on our current expectations, and are subject to a number of risks and uncertainties, including without limitation, that our Innodata Advanced Data Solutions segment has not reported any revenues to date and is subject to the risks and uncertainties of early-stage companies; the primarily at-will nature of the contracts between our Content Services segment and its customers and the ability of customers to reduce, delay or cancel projects; continuing Content Services revenue concentration in a limited number of customers; continuing Content Services reliance on project-based work; inability to replace projects that are completed, cancelled or reduced; depressed market conditions; changes in external market factors; the ability and willingness of our customers and prospective customers to execute business plans which give rise to requirements for digital content and professional services in knowledge processing; difficulty in integrating and deriving synergies from acquisitions, joint venture and strategic investments; potential undiscovered liabilities of companies that we acquire; changes in our business or growth strategy; the emergence of new or growing competitors; various other competitive and technological factors; and other risks and uncertainties indicated from time to time in our filings with the Securities and Exchange Commission.

Actual results could differ materially from the results referred to in the forward-looking statements. In light of these risks and uncertainties, there can be no assurance that the results referred to in the forward-looking statements contained in this release will occur.

AdCare Health Systems (ADK) to Present at the UBS 22nd Annual Global Healthcare Services Conference on February 7, 2012

SPRINGFIELD, OH — (Marketwire) — 02/06/12 — AdCare Health Systems, Inc. (NYSE Amex: ADK), a nursing home and assisted living company, has been invited to present at the UBS 22nd Annual Global Healthcare Services Conference. The conference will be held at the Grand Hyatt New York in New York City on February 7-8, 2012.

AdCare CEO Boyd Gentry, and its chief acquisition officer, Chris Brogdon, are scheduled to present on Tuesday, February 7, 2012 at 8:00 a.m. Eastern time, with one-on-one meetings held throughout the day. AdCare management will discuss the emerging opportunities in the highly fragmented health care segments of senior assisted living and elderly nursing care.

The company will also talk about the progress of AdCare’s M&A program designed to build upon its strong reputation for operational efficiency and high-quality living environments. With the recent acquisition of a skilled nursing and assisted living community in Ohio, plus 24 additional skilled nursing centers AdCare expects to close in the first quarter of 2012 and the Abington Place skilled nursing facility in Q2 2012, the company expects its annualized revenue run-rate to exceed $355 million, which would represent an increase of 570% over revenues in 2010.

The presentation will be broadcast simultaneously and available for replay at www.ibb.ubs.com/Conferences and the investor relations section of the company’s website at www.adcarehealth.com.

For more information about the conference or to schedule a one-on-one meeting with AdCare management, please contact your UBS representative or visit the conference website at www.ibb.ubs.com.

About UBS
Headquartered in Zurich and Basel, UBS is a global firm providing financial services to private, corporate and institutional clients. UBS is present in all major financial centers and has offices in over 50 countries. UBS employs more than 65,000 people around the world. UBS’s historical roots stretch back more than a century. For more information, visit www.ubs.com.

About AdCare Health Systems
AdCare Health Systems, Inc. (NYSE Amex: ADK) is a recognized innovator in senior living and health care facility management. AdCare develops, owns and manages assisted living facilities, nursing homes and retirement communities. Since its inception in 1988, AdCare’s mission has been to provide the highest quality of healthcare services to the elderly. For more information about AdCare, visit www.adcarehealth.com.

Important Cautions Regarding Forward-Looking Statements
Statements contained in this press release that are not historical facts may be forward-looking statements within the meaning of federal law. Such statements can be identified by the use of forward-looking terminology, such as “believes,” “expects,” “plans,” “intends,” “anticipates” and variations of such words or similar expressions, but their absence does not mean that the statement is not forward-looking. Statements in this announcement that are forward-looking include, but are not limited to, statements about the company’s expected annualized revenue run-rate and statements regarding the expected closing of transactions. Such forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available to management, and involve known and unknown risks, results, performance or achievements of AdCare which may differ materially from those expressed or implied in such statements. Such factors are identified in the public filings made by AdCare with the Securities and Exchange Commission and include, among others, AdCare’s ability to secure lines of credit and/or an acquisition credit facility, find suitable acquisition properties at favorable terms, changes in the health care industry because of political and economic influences, changes in regulations governing the industry, changes in reimbursement levels including those under the Medicare and Medicaid programs and changes in the competitive marketplace. There can be no assurance that such factors or other factors will not affect the accuracy of such forward-looking statements. Except where required by law, AdCare undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Company Contacts
Boyd Gentry, CEO
Chris Brogdon, Vice Chairman & CAO
David A. Tenwick, Chairman of Board
AdCare Health Systems, Inc.
Tel (937) 964-8974

Investor Relations
Ron Both or Geoffrey Plank
Liolios Group, Inc.
Tel (949) 574-3860

Misonix, Inc. (MSON) to Report Second Quarter Fiscal 2012 Financial Results on Wednesday, February 8, 2012

Orexigen (OREX) Announces Agreement From the FDA on a Special Protocol Assessment for the Contrave® Outcomes Trial

Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed’s (ENMD) Board of Directors

Cybex (CYBI) Reaches Settlement in Barnhard Product Liability Suit

Cybex International, Inc. (NASDAQ: CYBI), a leading manufacturer of premium exercise equipment, announced today that it has reached a settlement in the product liability litigation, Barnhard v. Cybex International, Inc. Pursuant to the settlement, Cybex will pay to the plaintiff, net of insurance, approximately $19,500,000, of which approximately $18,500,000 will be paid at the consummation of the settlement with the balance paid over seven years. As part of the settlement, Cybex will be released of all further liability with respect to the litigation, which will be dismissed with prejudice. Cybex will satisfy its cash obligation through available cash, its existing line of credit and additional financing, which it is in the process of arranging with its principal bank.

The settlement is subject to standard closing conditions, including the execution of a definitive settlement agreement by Cybex, the plaintiff and the third party defendant. Cybex anticipates that all conditions will be satisfied and funds disbursed within the next 30 days.

As previously reported, Cybex currently is subject to possible de-listing from the Nasdaq Stock Market due to its failure to comply with the Nasdaq requirements for a minimum stockholders’ equity of $10,000,000, a minimum bid price for its common stock of $1.00 per share and a minimum market value of publicly held shares of $5,000,000. Cybex is analyzing the impact the settlement will have on its financial statements. However, looking forward, Cybex is confident that, once the settlement is reflected in the Company’s financial statements, its stockholders’ equity will exceed the $10,000,000 minimum required by Nasdaq.

Cybex Chairman and CEO John Aglialoro states, “The positive financial impact of this settlement will be reflected in our Q4 results. As we move past this lawsuit, Cybex remains a healthy business and a leader in the fitness industry. We are confident of our future as we move forward with our Cybex team.”

Cybex anticipates announcing 2011 results on or around February 16, 2012.

About Cybex

Cybex International, Inc. is a leading manufacturer of premium exercise equipment primarily for commercial use. The Cybex product line, including a full range of strength and cardio training machines, is designed using exercise science to reflect the natural movement of the human body. Led by the Cybex Research Institute, Cybex fitness equipment is engineered to produce optimal results for users from the first-time exerciser to the professional athlete. Products are available for a wide range of facilities, from commercial health clubs to home gyms, and are sold in more than 85 countries worldwide. For more information on Cybex and its product lines, visit the Company’s website at www.cybexintl.com.

This news release may contain forward-looking statements. There are a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made above. These include, but are not limited to, the resolution of litigation involving the Company, the ability of the Company to comply with the terms of its credit facilities, competitive factors, technological and product developments, market demand, and economic conditions. Further information on these and other factors which could affect the Company’s financial results can be found in the Company’s previously filed Report on Form 10-K for the year ended December 31, 2010, its Reports on Form 10-Q, its Current Reports on Form 8-K, and its proxy statement dated April 14, 2011.

MissionIR Features AdCare Health Systems (ADK) in Exclusive Interview Featuring President and CEO Boyd Gentry

MissionIR today announces that its interview with Boyd Gentry, the president and chief executive officer of AdCare Health Systems (NYSE Amex: ADK), is now available online. The complete interview can be heard at http://adk.missionir.com/adk/interview.html.

Mr. Gentry discussed the company’s rapid growth, its aggressive M&A program, and acquisitions that are on the horizon for 2012, which are projected to increase the company’s revenue run rate by more than 500% over 2010. Mr. Gentry additionally provided an overview of the company’s business model and discussed the background of the company’s executive team, including recent additions of new talent. Mr. Gentry emphasized AdCare’s tremendous growth, which is singular among its competitors in these challenging economic times.

“We’re the only long-term care company that is aggressively acquiring these smaller, regionally focused, privately held, nursing home operators,” Mr. Gentry stated. “Typically, these acquisition targets are not focused on the more complex, but more profitable sub-acute segment of the business. AdCare is able to build upon the solid custodial care reputations of these smaller operators by expanding their clinical capabilities and post-acute services. Our revenues grew four-fold in 2010, and then last year we doubled to a run rate of $200 million. We have a number of acquisitions in the pipeline and expect by the end of this year to at least double again.”

About AdCare Health Systems, Inc.

AdCare Health Systems, Inc. (NYSE Amex: ADK) is a recognized innovator in senior living and health care facility management. AdCare develops, owns and manages assisted living facilities, nursing homes and retirement communities. Since its inception in 1988, AdCare’s mission has been to provide the highest quality of healthcare services to the elderly. For more information about AdCare, visit www.adcarehealth.com.

About MissionIR

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

To sign up for The MissionIR Report, please visit http://www.MissionIR.com

To connect with MissionIR via Facebook, please visit http://www.Facebook.com/MissionIR

To connect with MissionIR via Twitter, please visit http://www.Twitter.com/MissionIR

Please read FULL disclaimer on the MissionIR website: http://Disclaimer.MissionIR.com

Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company’s actual results to differ materially from those indicated in any forward-looking statements.

Mission Investor Relations
Atlanta, Georgia
http://www.MissionIR.com
404-941-8975
Investors@MissionIR.com

Overland Storage (OVRL) and TData Sign Strategic Distribution Agreement

Overland Storage (NASDAQ:OVRL), the trusted global provider of effortless data management and data protection solutions across the data lifecycle, today announced a new strategic agreement with TData, a Sydney-based value-added distributor with excellent technical competence in Storage and Networking, to distribute its award-winning storage solutions to the Australian marketplace.

Included in this agreement are the rights to distribute Overland’s end-to-end data management and protection solutions, including the SnapServer Network Attached Storage products, SnapSAN, NEO Series Tape Solutions and the REO VTL Series.

“‘We are delighted to be partnering with Overland Storage to provide their extensive range of data storage solutions though our reseller network in Australia,” said TData Director, Jeremy Campbell. “Overland’s longstanding reputation for high quality products, backed by strong local warranty support, will strengthen our solution offering for our clients and allow us to expand our reach in the enterprise and data centre space.”

Overland Storage will work with TData to drive channel expansion across various vertical markets. With a network of specialist resellers, systems integrators and service providers, TData is able to meet the growing need of SME resellers and customers that are looking for feature rich storage products. TData will place a particular emphasis on the recently launched SnapServer DX Series and the newly enhanced NEO Series tape libraries and autoloaders.

Andy Walsky, VP of Sales, Overland Storage, said: “We are pleased to partner with such an established distributor. TData’s expertise delivering professional services along with their long history in data management and protection make them a perfect partner to move forward our business development strategy in the ANZ region.”

About TData

Established in 1982, TData is a Storage, Networking and Database distributor specialist offering a solid range of quality products, underpinned by in-depth product knowledge and pre & post sales technical support. TData offers competitive pricing, fast delivery, exceptional support and rapid response times. For more information, visit http://www.tdata.com.au/.

About Overland Storage

Overland Storage is a trusted global provider of effortless data management and data protection solutions across the data lifecycle. By providing an integrated range of technologies and services for primary, nearline, offline, archival, and cloud data storage. For more information, visit www.overlandstorage.com.

Advanced Photonix, Inc. (API) Announces Banking Relationship with Silicon Valley Bank

Advanced Photonix, Inc.^® (NYSE Amex: API) today announced that it has established a new credit facility with Silicon Valley Bank, with regional headquarters in Chicago, IL. As part of this new banking relationship, the Company has repaid the short term note and line of credit previously held by The PrivateBank and Trust. The new credit facility is initially comprised of a three year term note of $1 million, and a two year $5 million revolving line of credit.

Richard Kurtz, President and CEO commented, “We are pleased to have established this new relationship with Silicon Valley Bank, a strong bank with a rich history of working with growing high technology businesses like API. I would also like to thank The PrivateBank and Trust for their support over the past four years. This new credit facility makes possible an increase in foreign receivable coverage up to $3 million as part of the $5 million total line. This increase in total credit facility will help us fund our growth, including our international revenue growth. We are very pleased with our new relationship with Silicon Valley bank, both for their commitment to API in particular and deep understanding of the high technology market.”

“We aim to increase the probability of our clients’ success and we’re looking forward to working closely with the Advanced Photonix team as they continue to grow,” said Mike Kohnen, Senior Relationship Manager, Silicon Valley Bank. “Since we are focused on technology innovators like API, we are able to provide them with the services and financing they need to expand internationally and tackle their ambitious goals.”

About Advanced Photonix, Inc.

Advanced Photonix, Inc.^® (NYSE Amex: API) is a leading supplier with a broad offering of optoelectronic products to a global customer base. We provide optoelectronic solutions, high-speed optical receivers and terahertz instrumentation for telecom, homeland security, military, medical and industrial markets. With our patented technology and state-of-the-art manufacturing we offer industry leading performance, exceptional quality, and high value-added products to our OEM customer base. For more information visit us on the web at www.advancedphotonix.com.

About Silicon Valley Bank

Silicon Valley Bank is the premier bank for technology, life science, cleantech, venture capital, private equity and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment and international banking services to its clients worldwide through 26 U.S. offices and seven international operations. (Nasdaq: SIVB) www.svb.com.

Silicon Valley Bank is the California bank subsidiary and the commercial banking operation of SVB Financial Group. Banking services are provided by Silicon Valley Bank, a member of the FDIC and the Federal Reserve System. SVB Private Bank is a division of Silicon Valley Bank. SVB Financial Group is also a member of the Federal Reserve System.

The information contained herein includes forward looking statements that are based on assumptions that management believes to be reasonable but are subject to inherent uncertainties and risks including, but not limited to, unforeseen technological obstacles which may prevent or slow the development and/or manufacture of new products; potential problems with the integration of the acquired company and its technology and possible inability to achieve expected synergies; obstacles to successfully combining product offerings and lack of customer acceptance of such offerings; limited (or slower than anticipated) customer acceptance of new products which have been and are being developed by the Company; and a decline in the general demand for optoelectronic products. API-G

Threshold Pharmaceuticals (THLD) and Merck KGaA Announce Global Agreement

SOUTH SAN FRANCISCO, CA — (Marketwire) — 02/03/12 — Threshold Pharmaceuticals, Inc (NASDAQ: THLD)

• Threshold to receive $25 million upfront, plus further potential milestones and royalties
• Deal provides Threshold option to co-commercialize in the United States
• Phase 3 trial in soft tissue sarcoma on-going and randomized Phase II trial in patients with pancreatic cancer expected to report in February 2012

Threshold Pharmaceuticals, Inc (NASDAQ: THLD) today announced that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug. TH-302 is currently being investigated in a global Phase 3 clinical trial in patients with soft tissue sarcoma, a randomized Phase 2 trial in patients with advanced pancreatic cancer from which top-line results are expected in February, as well as additional clinical studies in other solid tumors and hematological malignancies.

Under the terms of the agreement, Merck will receive co-development rights, exclusive global commercialization rights and will provide Threshold an option to co-commercialize the therapeutic in the United States. In exchange, Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012. Threshold is also eligible to receive a $20 million milestone payment based on positive results from its randomized Phase 2 trial in pancreatic cancer. Total potential milestone payments are $525 million, comprised of $280 million in regulatory and development milestones and $245 million in sales-based milestones.

In the United States, Threshold will have primary responsibility for development of TH-302 in the soft tissue sarcoma indication. Threshold and Merck KGaA will jointly develop TH-302 in all other cancer indications being pursued. Merck KGaA will pay 70% of worldwide development costs for TH-302.

Subject to FDA approval in the United States, Merck KGaA will initially be responsible for commercialization of TH-302 with Threshold receiving a tiered, double-digit royalty on sales. Under the royalty-bearing portion of the agreement, Threshold retains the option to co-promote TH-302 in the United States. Additionally, Threshold retains the option to co-commercialize TH-302 allowing the company to participate in up to 50% of the profits in the United States based on certain revenue tiers. Outside of the United States, Merck KGaA will be solely responsible for the commercialization of TH-302 with Threshold receiving a tiered, double-digit royalty on sales in these territories.

“The addition of TH-302 to our pipeline provides an important opportunity in several different tumor types to expand our oncology development program,” said Susan Jane Herbert, Head of Global Business Development and Strategy, Merck Serono. “Given the fact that pancreatic cancer is a very difficult to treat indication, successful Phase II results could represent an important upside for our company.”

“We are excited by the new resources that our partnership is going to bring to the development of TH-302 and the expertise in clinical development and commercialization that Merck will contribute to this program,” said Barry Selick, President and CEO of Threshold. “This collaboration provides Threshold a strong and committed partner with a shared vision for TH-302.”

Morrison & Foerster LLP acted as legal counsel for Threshold in this transaction.

About TH-302
TH-302 is a hypoxia-targeted drug that is thought to be activated under tumor hypoxic conditions, a hallmark for many cancer indications. Areas of low oxygen levels (hypoxia) within tissues are common in many solid tumors due to insufficient blood vessel growth. Similarly, the bone marrow of patients with hematological malignancies has also been shown, in some cases, to be extremely hypoxic.

TH-302 has been investigated in over 550 patients in Phase I/II clinical trials to date in a broad spectrum of tumor types, both as a monotherapy and in combination with chemotherapy treatments and other targeted cancer drugs.

Threshold has several ongoing clinical trials including, but not limited to, a controlled Phase 2 trial of TH-302 in combination with gemcitabine versus gemcitabine alone in patients with advanced pancreatic cancer and a Phase 3 study evaluating TH-302 in combination with doxorubicin versus doxorubicin alone in patients with soft tissue sarcoma.

TH-302 development in soft tissue sarcoma

A Phase 3 trial of TH-302 in patients with first-line advanced soft tissue sarcoma (STS) was initiated in September 2011, based on results from a Phase 1/2 trial investigating its use in combination with the chemotherapeutic doxorubicin. This randomized, multi-center Phase 3 trial will investigate the use of TH-302 plus doxorubicin compared with doxorubicin alone. The primary efficacy endpoint is overall survival. The study is conducted under a Special Protocol Assessment with the U.S. Food and Drug Administration. It is being run in partnership with the Sarcoma Alliance for Research through Collaboration (SARC) and aims to enroll 450 patients with metastatic or locally advanced unresectable STS.

TH-302 development in pancreatic cancer

Results from a randomized, controlled, multi-center Phase 2 trial of TH-302 in patients with first-line pancreatic cancer are expected to be announced in February 2012. This trial of 214 previously untreated patients with locally advanced unresectable or metastatic pancreatic adenocarcinoma started in June 2010, and completed enrollment in June 2011. Two different doses of TH-302 in combination with the chemotherapeutic gemcitabine were compared to gemcitabine alone, with progression free survival (PFS) as the primary endpoint.

Soft tissue sarcoma

Sarcomas are a group of aggressive cancers of connective tissue of the body for which there are currently limited treatment options. Soft tissue sarcomas are treated with surgery, chemotherapy and radiation. Doxorubicin as a single agent or in combination with ifosfamide are the most commonly used chemotherapeutic regimens in patients with advanced soft tissue sarcoma, but response rates are generally low and toxicity can be significant. The American Cancer Society estimates that 10,980 people were diagnosed with a soft tissue sarcoma in the United States in 2011, and approximately 3,920 people died from the disease. In Europe, it is estimated that more than 32,000 people were diagnosed with soft tissue sarcoma in 2010.

Pancreatic cancer

Pancreatic cancer is a malignant neoplasm of the pancreas with current treatment options including surgery, radiotherapy and chemotherapy. Gemcitabine as a single agent or in combination with other treatments is the most commonly used chemotherapeutic agent in patients with advanced pancreatic cancer. It is estimated that approximately 279,000 cases of pancreatic cancer were diagnosed worldwide in 2008. Pancreatic cancer is the fourth most common cause of cancer death both in the United States and internationally. The American Cancer Society estimates that 44,030 people were diagnosed with pancreatic cancer in the United States in 2011, and approximately 37,660 people died from the disease.

About Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono discovers, develops, manufactures and markets prescription medicines of both chemical and biological origin in specialist indications. In the United States and Canada, EMD Serono operates as a separately incorporated affiliate of Merck Serono.

Merck Serono has leading brands serving patients with cancer (Erbitux®, cetuximab), multiple sclerosis (Rebif®, interferon beta-1a), infertility (Gonal-f®, follitropin alfa), endocrine and metabolic disorders (Saizen® and Serostim®, somatropin), (Kuvan®, sapropterin dihydrochloride), (Egrifta®, tesamorelin), as well as cardiometabolic diseases (Glucophage®, metformin), (Concor®, bisoprolol), (Euthyrox®, levothyroxine). Not all products are available in all markets.

With an annual R&D expenditure of over EUR 1bn, Merck Serono is committed to growing its business in specialist-focused therapeutic areas including neurodegenerative diseases, oncology, fertility and endocrinology, as well as new areas potentially arising out of research and development in rheumatology.

About Merck

Merck is a global pharmaceutical and chemical company with total revenues of EUR 9.3 billion in 2010, a history that began in 1668, and a future shaped by more than 40,000 employees in 67 countries. Its success is characterized by innovations from entrepreneurial employees. Merck’s operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

For more information, please visit www.merckserono.com or www.merckgroup.com

About Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of patients with some hematologic malignancies. For additional information, please visit the company’s website: www.thresholdpharm.com.

Forward-Looking Statements
Except for statements of historical fact, the statements in this press release are forward-looking statements, including statements regarding potential payments from Merck to Threshold, development and commercialization plans for TH-302, TH-302’s potential ability to treat soft tissue sarcoma and pancreatic cancer, planned clinical trials and anticipated results, and potential therapeutic uses and benefits of TH-302. These statements involve risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, Threshold’s ability to accomplish milestones that will trigger payments, Threshold’s and Merck’s ability to enroll or complete its anticipated clinical trials, the time and expense required to conduct such clinical trials and analyze data, whether such trials confirm results from earlier trials and preclinical studies, potential side effects associated with TH-302, issues arising in the regulatory or manufacturing process and the results of such clinical trials (including product safety issues and efficacy results), and Threshold’s and Merck’s ability to obtain regulatory approval for the marketing of TH-302. Further information regarding these and other risks is included under the heading “Risk Factors” in Threshold’s Quarterly Report on Form 10-Q, which has been filed with the Securities Exchange Commission on November 3, 2011 and is available from the SEC’s website (www.sec.gov) and on our website (www.thresholdpharm.com) under the heading “Investors.” We undertake no duty to update any forward-looking statement made in this news release.

Contact:
Joel A. Fernandes
Threshold Pharmaceuticals, Inc.
650.474.8273
IR@thresholdpharm.com

Silver Bull (SVBL) Intersects 9.81% Zinc Over 46.4 Meters and 100g/T Silver Over 43 Meters

Vancouver, British Columbia CANADA, February 01, 2012 /FSC/ – Silver Bull Resources Inc. (SVB – TSX, SVBL – NYSE Amex), is pleased to announce drill results from the 2011 drill campaign on the “Shallow Silver Zone”.

Highlights include;
* Results from 75 diamond core drill holes into the “Shallow Silver Zone”, equating to 11,700 meters of the 36,800 meter drill campaign completed in 2011.
* 80% of the drill holes intersected zones of silver oxide mineralization >30g/t Ag, including; 100g/t Ag over 43 meters, 170g/t over 11 meters and 213.4g/t Ag over 36.25 meters.
* Significant zinc intercepts including; 9.81% Zn over 46.4 meters, 17.47% Zn over 13.15 meters, and 9.03% Zn over 17.5 meters.

Silver Bull’s 2011 drill program of 183 drill holes totals 36,800 meters and focused on both the “Shallow Silver Zone” and the newly discovered “Centenario” zone. The program was designed to infill zones of mineralization defined by previous drilling as well as continue expanding the resource in the north, east, and westerly directions through step out drilling. The results have confirmed the continuity and tenor of the extensive silver and zinc mineralization seen at Sierra Mojada, and mineralization remains open in all directions. Silver Bull’s drill program is ongoing with 3 rigs currently onsite. Please see www.silverbullresources.com for more information.

A table of selected intervals from the reported 75 holes is shown below.

-***-
————————————————————-
Hole ID From(m) To(m) Interval Ag g/t Zn % Pb% Cu%
————————————————————-
B11002 53.00 68.00 15.00 25.45 1.45 0.36 0.04
B11003* 78.00 85.00 7.00 80.5 0.36 1.09 0.12
102.00 111.00 9.00 35.26 0.10 0.01 0.07
B11004* 96.10 116.75 20.65 36.85 0.07 0.08 0.06
122.00 132.20 10.20 36.96 0.01 0.07 0.02
B11005* 89.40 100.00 10.60 52.73 0.25 1.05 0.12
B11006 24.05 29.60 5.55 142.5 0.86 0.16 0.28
B11007 81.35 98.85 17.50 35.8 9.03 1.22 0.00
B11009* 104.90 119.00 14.10 37.25 0.31 0.07 0.11
B11010* 110.25 146.50 36.25 213.4 1.29 0.79 0.80
B11012 69.25 88.00 18.75 43.17 0.30 0.06 0.15
B11019 188.00 196.00 8.00 78.69 6.81 0.77 0.11
B11021 160.00 168.00 8.00 57.30 0.05 0.01 0.15
B11028 108.00 121.00 13.00 56.67 2.46 0.76 0.08
————————————————————-
Hole ID From(m) To(m) Interval Ag g/t Zn % Pb% Cu%
————————————————————-
B11034 146.00 149.00 3.00 142.69 1.78 0.31 1.09
B11037 168.00 194.00 26.00 39.16 0.10 0.01 0.06
B11042 5.80 22.00 16.20 33.27 1.04 0.19 0.00
B11044 28.00 53.65 25.65 55.7 0.56 0.07 0.26
B11045 28.00 71.00 43.00 100 1.22 0.42 0.01
B11046 10.30 27.00 16.70 62.90 2.22 0.41 0.07
B11047 21.00 56.00 35.00 25.57 0.18 0.04 0.05
B11048 49.00 60.00 11.00 170 1.40 1.99 0.03
78.00 82.25 4.25 31.92 0.30 0.05 0.00
90.00 94.00 4.00 27.75 0.17 0.01 0.00
B11050 122.95 169.35 46.40 19.44 9.81 0.16 0.00
B11051 31.95 87.00 55.05 55.45 1.71 1.27 0.03
B11054 32.00 97.50 65.50 28.47 0.82 0.06 0.06
B11056 55.70 123.00 67.30 44.64 0.25 0.07 0.03
161.65 172.00 10.35 52.54 6.89 0.13 0.08
B11066 36.05 57.00 20.95 77.68 0.25 0.06 0.07
B11067 138.25 151.40 13.15 75.66 17.47 1.25 0.00
B11068 36.45 96.00 59.55 19.29 0.12 0.06 0.00
B11069 129.00 136.15 7.15 44.9 1.82 0.52 0.13
B11070 114.20 129.45 15.25 80.86 3.06 0.79 0.04
B11071 45.65 118.00 72.35 36.87 0.21 0.08 0.00
B11072 133.40 150.10 16.70 31.09 5.49 0.61 0.00
B11073 0.00 69.00 69.00 35.45 0.86 0.20 0.00
79.85 97.30 17.45 19.21 0.86 0.03 0.00
————————————————————-
-****-

* Drillholes that were previously reported by Silver Bull
** Intervals shown are mineralized lengths of core and are not necessarily true widths.

About the Mineralization: A thick “upper” dolomite unit is the favorable host rock for the silver oxide mineralization seen in the Shallow Silver Zone, especially when immediately adjacent to fault zones. The discovery of the new “Centenario Zone” at the end of 2011, which is hosted within a strategraphically “lower” dolomite unit and averages +100 meter intercepts at >60g/t Ag underlies the upper dolomite which hosts the Shallow Silver Zone and was not tested by many of the early holes drilled in 2011. During the first quarter of 2012 a number of these holes will be deepened to see if the mineralization seen in the Centenario zone continues to the south within the lower dolomite. Sections 631500E and 631600E shown below demonstrate this concept.

Figure 1. Location of the reported holes in relation to the shallow silver zone defined in the NI43-101 Resource report completed by SRK in October 2011.

To view Figure 1, please click on the link below:
http://www.usetdas.com/pr/silverbull02012012figure1.jpg

Figure 2. Section 631500E showing the “Shallow Silver” and “Centenario” Zones in relation to the upper and lower dolomite units. It is planned that the lower dolomite unit will be explored in 2012 by deepening a number of holes drilled early in the 2011 drill campaign. Only drill holes with the prefix “B11” were drilled in 2011.

To view Figure 2, please click on the link below:
http://www.usetdas.com/pr/silverbull02012012figure2.jpg

Figure 3. Section 631600E showing the “Shallow Silver” and “Centenario” Zones in relation to the upper and lower dolomite units. It is planned that the lower dolomite unit will be explored in 2012 by deepening a number of holes drilled early in the 2011 drill campaign. Only drill holes with the prefix “B11” were drilled in 2011.

To view Figure 3, please click on the link below:
http://www.usetdas.com/pr/silverbull02012012figure3.jpg

About the Shallow Silver Zone: Currently contains a NI43-101 compliant resource at a 15g/t cutoff grade of 47.3Moz of silver in the “indicated” category and 13.8Moz of silver in the “inferred” category. The mineralized body averages between 30m – 90m thick, is up to 200m wide and has an average grade of just over 50g/t silver. Mineralization remains open in the east, west, south and northerly directions. Approximately 60% of the current 3.2 kilometer mineralized body is at or near surface before dipping at around 10 degrees to the east.

NI43-101 Resource Update: The third in a series of NI43-101 resource updates is anticipated to be prepared by SRK Consulting (Canada) Inc. “SRK” in Q2 of 2012. All available data up to February 28, 2012 will be given to SRK for inclusion in the report. Given the drilling results to date it is anticipated that SRK’s next report will show a substantial increase in the silver resource at Sierra Mojada, as well as including a resource for the significant zinc mineralization seen on the project.

Sample Analysis and QA/QC: All samples have been analyzed at ALS Chemex in North Vancouver, BC, Canada. Samples are first tested with the “ME-ICP41m” procedure which analyzes for 35 elements using a near total aqua regia digestion. Samples with silver values above 100ppm are re-analyzed using the Ag-GRA21 procedure which is a fire assay with a gravimetric finish. Samples with zinc, lead, and copper values above 10,000ppm (1%) are re-analyzed using the AA46 procedure which is a near total aqua regia digestion with an atomic absorption finish.

A rigorous procedure is in place regarding sample collection, chain of custody and data entry. Certified standards and blanks, as well as duplicate samples are routinely inserted into all sample shipments to ensure integrity of the assay process. The QA/QC of the assay results has been contracted to IOGlobal, an international and independent QA/QC and database management firm.

About Silver Bull: Silver Bull is a well funded, US registered mineral exploration company listed on both the NYSE Amex and TSX stock exchanges and based out of Vancouver, Canada. The flag ship “Sierra Mojada” project is located 150 kilometers north of the city of Torreon in Coahuila, Mexico and is highly prospective for silver and zinc. Silver Bull also owns three mineral exploration licences in Gabon, Africa, two of which are currently under joint venture with AngloGold Ashanti. These licences are prospective for gold, manganese, and iron ore.

The technical information of this news release has been reviewed and approved by Jason Cunliffe, MAusIMM, a qualified person onsite for the purposes of National Instrument 43-101.

INVESTOR RELATIONS CONTACT INFO:
info@silverbullresources.com

Cautionary Note to U.S. Investors concerning estimates of Indicated and Inferred Resources: This press release uses the terms “indicated resources” and “inferred resources” which are defined in, and required to be disclosed by, NI 43-101. We advise U.S. investors that these terms are not recognized by the United States Securities and Exchange Commission (the “SEC”). The estimation of indicated resources involves greater uncertainty as to their existence and economic feasibility than the estimation of proven and probable reserves. U.S. investors are cautioned not to assume that indicated mineral resources will be converted into reserves. The estimation of inferred resources involves far greater uncertainty as to their existence and economic viability than the estimation of other categories of resources. U.S. investors are cautioned not to assume that estimates of inferred mineral resources exist, are economically minable, or will be upgraded into measured or indicated mineral resources. Under Canadian securities laws, estimates of inferred mineral resources may not form the basis of feasibility or other economic studies.

Disclosure of “contained ounces” in a resource is permitted disclosure under Canadian regulations, however the SEC normally only permits issuers to report mineralization that does not constitute “reserves” by SEC standards as in place tonnage and grade without reference to unit measures. Accordingly, the information contained in this press release may not be comparable to similar information made public by U.S. companies that are not subject NI 43-101.

Cautionary note regarding forward looking statements: This news release contains forward-looking statements regarding future events and Silver Bull’s future results that are subject to the safe harbors created under the Securities Act of 1933 (the “Securities Act”) and the Securities Exchange Act of 1934 (the “Exchange Act”) and applicable Canadian securities laws. Forward-looking statements include statements regarding indicated and inferred resource estimates, the anticipated scope and targets of future drilling in the Shallow Silver Zone and Centenario Zone and the timing and expected resource increase of Silver Bull’s next resource update. These statements are based on current expectations, estimates, forecasts, and projections about Silver Bull’s exploration projects, the industry in which Silver Bull operates and the beliefs and assumptions of Silver Bull’s management. Words such as “expects,” “anticipates,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “continues,” “may,” variations of such words, and similar expressions, are intended to identify such forward-looking statements. Forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, including such factors as the results of exploration activities and whether the results continue to support continued exploration activities, unexpected variations in ore grade, types and metallurgy, volatility and level of commodity prices, the availability of sufficient future financing, and other matters discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended October 31, 2011 and our other periodic and current reports filed with the SEC and available on www.sec.gov and with the Canadian securities commissions available on www.sedar.com. Readers are cautioned that forward-looking statements are not guarantees of future performance and that actual results or developments may differ materially from those expressed or implied in the forward-looking statements.

To view this release as a web page, please click on the following link:
http://www.usetdas.com/pr/silverbull02012012.htm

TMNG Global (TMNG) Launches MDLx(SM), Breakthrough Mobile Device Leasing Solution

OVERLAND PARK, Kan., Feb. 1, 2012 (GLOBE NEWSWIRE) — TMNG Global (Nasdaq:TMNG), a premier provider of professional services and software solutions to the global leaders in the communications, digital media and technology industries, today announced a game-changing development for wireless carriers, their subscribers and device manufacturers with the first-ever mobile device leasing solution – Mobile Device Lease xChange (MDLx). MDLx is a third party administration (TPA) company that provides (1) a comprehensive and integrated business and operating model for mobile device leasing; and (2) the complete technology platform for lease administration and accounting.

“The economics of the mobile device market are complex and particularly burdensome for carriers, who must offer the latest technology at affordable price points. Escalating smartphone prices, higher subsidies absorbed by carriers, market-driven caps on consumer upfront payments and regulatory pressure to eliminate early termination fees – are all factors which contribute to frustrations for carriers, subscribers and even the OEMs,” said Don Klumb, TMNG Global’s CEO. “We think the market is ready for a viable smartphone leasing option. MDLx provides a complete solution that enables carriers to dramatically reduce their device subsidy obligations; provide subscribers access to the latest device technology as it becomes available and on a more frequent basis; and also benefits OEMs by decreasing their sales cycles by half and facilitating development of new technology with less concern for carrier subsidy constraints.”

Building upon TMNG’s proven business and operations support systems capabilities, as well as its Ascertain® software suite and its acquisition of an industry-proven TPA platform, MDLx has created an innovative, technology-based ecosystem for managing the entire mobile device leasing program structure. MDLx enables efficient, end-to-end support for carriers’ premises and billing systems, and back-end lease aggregation and management platform, including administration, finance, insurance, and handset recovery and redeployment capabilities.

“Our experience with handset recapture models, including our own SmartXchange offering, has proven that the rapidly advancing sophistication of smartphones gives them attractive residual values,” said Tom Murphy, MDLx’s Chief Marketing Officer. “The ability to capture that residual value is the basis for successful application of a lease model, and is what enables MDLx to pioneer an offering that’s highly compelling for players throughout the smartphone food chain. By designing an end-to-end, fully administered solution that addresses the pain points of carriers, subscribers and OEMs, we think MDLx offers the wireless industry a new option for dramatically improving its economic model.”

About MDLx

MDLx, a wholly-owned subsidiary of parent company, TMNG Global (Nasdaq:TMNG), provides carriers with an end-to-end solution, Mobile Device Lease xChange, that reduces the economic impact of handset subsidies, while providing consumers with access to more frequent mobile device upgrade opportunities. MDLx also allows OEMs to decrease sales cycles by half, while facilitating development of new technology with less concern for carrier subsidy constraints. For more information, visit www.deviceleasing.com.

The MDLx Logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=11523

About TMNG Global

TMNG Global (Nasdaq:TMNG) is a premier provider of professional services to the global leaders in the communications, digital media, and technology industries. TMNG Global and its divisions, CSMG and Cartesian, and a team of more than 500 experts, provide strategy, operations and technology consulting services and technical solutions to more than 1,200 communications clients worldwide. The company is headquartered in Overland Park, Kansas, with offices in Boston, London, New Jersey, and Washington, D.C. For more information about the company and its services, visit www.tmng.com.

CONTACT: Brainerd Communicators
         Ray Yeung / Jo Anne Barrameda (Media)
         yeung@braincomm.com / barrameda@braincomm.com
         212.986.6667

         Corey Kinger (Investors)
         kinger@braincomm.com
         212.986.6667

Shire (SHPGY) and Sangamo (SGMO) Collaborate to Develop Therapeutics for the Treatment of Hemophilia and Other Monogenic Diseases

Quantum Technologies, Inc. (QTWW) to Present at Merriman Capital Investor Summit 2012

Corinthian Colleges (COCO) Reports Fiscal 2012 Second Quarter Results

SANTA ANA, Calif., Feb. 1, 2012 (GLOBE NEWSWIRE) — Corinthian Colleges, Inc. (Nasdaq:COCO) reported financial results today for the second quarter ended December 31, 2011. The results for the quarter exceeded previous guidance ranges for earnings per share and were within previous guidance ranges for revenue and new student enrollment.

“In the second quarter we remained focused on student outcomes, balancing expenses with current and projected enrollment, and improving the efficiency of back-end operations,” said Jack Massimino, Corinthian Chairman and Chief Executive Officer. “Our student attrition and graduate employment trends continue to make incremental improvement, primarily the result of reducing the risk profile of our students and our ongoing efforts to help students succeed.”

“As anticipated, the rate of decline in new student enrollment growth improved significantly in the quarter,” Massimino said. “The improvement is the result of several factors, including a less challenging comparable from the second quarter last year, gradual stabilization in ground school new enrollments and continued strong growth at Everest University Online. In the last half of fiscal 2012, we expect new enrollments to be slightly positive.”

“To help offset recent declines in student population, over the past 18 months we have reduced annualized operating expenses by approximately $150 million,” Massimino said. “We also continue to pursue several growth initiatives, such as introducing new program offerings, opening new campuses, and growing our exclusively online enrollments.”

Comparing the second quarter of fiscal 2012 with the same quarter of the prior year:

• Net revenues were $415.5 million versus $481.7 million, a decrease of 13.7%.
• The total student population at December 31, 2011 was 94,860 versus 105,210 at December 31, 2010, a decrease of 9.8%.
• New student enrollments totaled 25,951 versus 26,758, a decrease of 3.0%.

• Operating income was $10.0 million, excluding severance charges of $2.7 million, compared with operating income of $33.1 million, excluding impairment and severance charges of $206.0 million in the second quarter of fiscal 2011.
• Net income, excluding impairment and severance for both periods, was $3.4 million, compared with $19.1 million in the prior year.
• Diluted earnings per share were $0.02 per share versus a diluted loss per share of $(1.94). Excluding impairment and severance charges of $0.02 per share in Q2 12 and $2.17 per share in Q2 11, diluted earnings per share were $0.04 in Q2 12 versus $0.23 in Q2 11.

Financial Review

Educational services expense decreased $33.0 million, or 11.4%, from $288.6 million in Q2 11 to $255.6 million in Q2 12. As a percent of revenue, educational services expense increased from 59.9% in Q2 11 to 61.5% in Q2 12. The increase as a percent of revenue is primarily due to an increase in compensation and facilities expense, reflecting the fixed nature of these expenses against a lower revenue base, partially offset by improvement in bad debt expense.

Bad debt expense decreased to $14.6 million or 3.5% of net revenues for Q2 12 compared to $31.6 million or 6.6% of net revenues for Q2 11. The improvement in bad debt expense is primarily the result of continued efficiencies in packaging students with financial aid as a result of bringing processing in-house.

Marketing and admissions expenses decreased $2.0 million, or 1.9%, from $106.0 million in Q2 11 to $104.0 million in Q2 12. As a percent of revenue, marketing and admissions increased from 22.0% in Q2 11 to 25.0% in Q2 12. The increase as a percent of revenue is primarily attributable to a lower revenue base.

General and administrative expenses decreased $8.2 million, or 15.2% from $54.0 million in Q2 11 to $45.8 million in Q2 12. As a percent of revenue, G&A decreased from 11.2% in Q2 11 to 11.0% in Q2 12. The decrease reflects the company’s cost reduction initiatives.

Impairment and severance charges – During the second quarter, we recorded severance charges of $2.7 million.

The operating margin, excluding the impairment, facility closing and severance charges in both time periods, was 2.4% in Q2 12 versus 6.9% in Q2 11. The decline is primarily the result of lower enrollment in the ground schools, and fixed compensation and facilities expenses against a lower revenue base.

Cash and cash equivalents totaled $38.4 million at December 31, 2011, compared with $107.4 million at June 30, 2011. The decrease results from the repayment of debt, partially offset by cash flows from operations.

Total debt and capital leases were $135.3 million at December 31, 2011, compared with $331.8 million at June 30, 2011.

Cash flow from operations was $137.2 million in the first six months of fiscal 2012, versus $4.0 million in the same period last year. The increase in cash flow is primarily related to the timing of cash payments and receipts related to working capital.

Capital expenditures were $20.1 million for the first six months of fiscal 2012, versus $65.8 million in the same period last year. The decrease is primarily the result of opening fewer new campuses.

Other

The company has signed a definitive agreement for the sale-leaseback of five of its Heald College facilities. The transaction is expected to generate proceeds of approximately $40 million, and close in mid-February, subject to customary closing conditions.

Guidance

The following guidance excludes one-time charges:

Conference Call Today

We will host a conference call today at 12:00 p.m. Eastern Time (9:00 a.m. PT), to discuss second quarter results. The call will be open to all interested investors through a live audio web cast at www.cci.edu (Investor Relations/Events & Presentations.) The call will be archived on www.cci.edu after the call. A telephonic playback of the conference call will also be available through 11:00 p.m. PT, Wednesday, February 8. The playback can be reached by dialing (800) 585-8367 and using pass code 35917278.

About Corinthian

Corinthian is one of the largest post-secondary education companies in North America. Our mission is to change students’ lives. We offer diploma and degree programs that prepare students for careers in demand or for advancement in their fields. Our program areas include health care, business, criminal justice, transportation technology and maintenance, construction trades and information technology. We have 123 Everest, Heald and WyoTech campuses, and also offer degrees exclusively online. For more information, go to http://www.cci.edu/.

The Corinthian Colleges, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8848

Certain statements in this press release may be deemed to be forward-looking statements under the Private Securities Litigation Reform Act of 1995. The company intends that all such statements be subject to the “safe-harbor” provisions of that Act. Such statements include, but are not limited to, those regarding our beliefs and expectations regarding student outcomes; new student enrollment growth or declines in future periods; expected savings from our decision to align organizational expenses with lower enrollments; the success of our initiatives to increase new enrollments now and in the future, including the introduction of new programs, opening new campuses, and growing our exclusively online enrollments; the statements regarding future operational performance, including the statements under the heading “Guidance” above, and the expected closing of the sale-leaseback of five Heald College facilities. Many factors may cause the company’s actual results to differ materially from those discussed in any such forward-looking statements or elsewhere, including: the effect of new Department of Education rules; the company’s effectiveness in its regulatory and accreditation compliance efforts; the outcome of ongoing reviews and inquiries by accrediting, state and federal agencies, including state attorneys general, the U.S. Department of Education’s Office of the Inspector General, and the U.S. Attorney’s office in Georgia; the outcome of pending litigation against the company; the possible non-satisfaction of the conditions to closing of the company’s sale-leaseback transaction for its five Heald College facilities; risks associated with variability in the expense and effectiveness of the company’s advertising and promotional efforts; potential increased competition; bad debt expense or reduced revenue associated with requesting students to pay more of their educational expenses while in school; risks associated with the company’s new student lending program through ASFG; changes in general macroeconomic and market conditions (including credit and labor market conditions, the unemployment rate and the rates of change of each such item); and the other risks and uncertainties described in the company’s filings with the U.S. Securities and Exchange Commission. The historical results achieved by the company are not necessarily indicative of its future prospects. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Investors:
         Anna Marie Dunlap
         SVP Investor Relations
         714-424-2678

         Media:
         Kent Jenkins
         VP Public Affairs Communications
         202-682-9494

China Auto Logistics (CALI) Adding Automobile Insurance to Its “One Stop” Services; Also Announces Doubling of Credit Lines

TIANJIN, CHINA — (Marketwire) — 01/30/12 — China Auto Logistics Inc. (the “Company”) (NASDAQ: CALI), one of China’s leading developers of websites for buyers and sellers of imported and domestic automobiles, a top seller in China of imported luxury cars, and a leading provider of auto-related services, announced today a series of agreements with several leading Chinese banks and insurers which it expects will permit further rapid expansion of its auto-related services businesses, including a new service of providing auto insurance to individual consumers and dealers.

Cooperation Agreement with Five Leading Auto Insurers

The Company reported it has now concluded cooperation agreements with five of the leading auto insurance providers in China under which the Company will be qualified to offer automobile insurance to purchasers of automobiles in its auto mall, the largest imported luxury auto mall in Tianjin.

“Auto insurance is particularly important to buyers of the luxury cars we sell,” stated Mr. Tong Shiping, CEO and Chairman of the Company, “and we now will be able to offer the very best insurance packages to our customers. We see this as an excellent addition to the ‘one stop services’ we currently provide and further expect it will attract new customers and help boost our luxury auto sales in this very strong market.” Mr. Tong noted discussions regarding final details on how to best execute the agreements with each insurer are in progress and the new service is expected to be launched shortly.

Increased Support from Three Leading Banks

The Company also announced an expansion of its cooperation with three leading Chinese banks which it expects will lead to the further strengthening and growth of its auto-related services.

• Under an agreement reached with Bank of China (BOC), one of China’s four largest state-owned commercial banks, the Company will soon offer its luxury auto customers the option of installment buying.
• Through an agreement developed with China Merchant Bank (CMB), the Company will soon establish an electronic payment platform which, among other things, will help the Company manage cash flow more efficiently.
• Agricultural Bank of China has agreed to grant the Company a credit line of RMB 960 million (approximately $152 million) which by itself would represent an approximate doubling of the Company’s current aggregate credit line with several domestic banks.

An Opportunity to Expand

Commenting further on these developments, Mr. Tong stated, “Our expanded credit lines, the new cooperation with BOC and CMB, and our new insurance services business in cooperation with five of China’s leading insurers, absolutely places us in a much stronger position to offer our auto related services to more dealer customers and consumers, as well as the opportunity to expand our business to a wider marketplace throughout China.”

About China Auto Logistics Inc.

China Auto Logistics Inc. operates www.cali.com.cn, one of the leading automobile portals for car dealers and consumers of vehicles and auto-related services in China. Additionally, it is one of China’s top sellers of luxury imported cars and a leading developer of websites for buyers and sellers of imported and domestic automobiles. These include www.188.com, China’s only site for imported car dealers and consumers; www.at160.com, focused on domestic auto sales, and www.goodcar.cn, a highly popular internet destination for auto drivers attracted by discount cards for a variety of automotive products and services. The Company believes the integration of these wide ranging sites and services in a single portal serving a broad spectrum of China’s “auto living” public, as well as the addition of new web-based auto-related services for businesses and consumers, will drive future growth. For additional information visit www.chinaautologisticsinc.com.

Information Regarding Forward-Looking Statements

Except for historical information contained herein, the statements in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause our actual results in future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product demand, market competition, and risks inherent in our operations. These and other risks are described in our filings with the U.S. Securities and Exchange Commission.

US Contact:

Ken Donenfeld
DGI Investor Relations
kdonenfeld@dgiir.com
Tel: 212-425-5700
Fax: 646-381-9727

Central European Distribution (CEDC) Signs an Agreement With William Grant and Sons

WARSAW, Poland, Jan. 30, 2012 /PRNewswire/ – Central European Distribution Corporation (NASDAQ: CEDC), one of the leading vodka producers in the world, would like to announce that First Drinks Brands, part of William Grant & Sons, will have the exclusive importation rights to Green Mark, Zubrowka and Kauffman Vodka in the United Kingdom. The agreement strengthens CEDC and William Grant & Sons’ international alliance, within which CEDC imports and distributes brands from William Grant & Sons’ portfolio in Poland and Hungary.

Green Mark is the no. 1 vodka brand in the Russian market and one of the top vodka brands in the world, with annual sales of approximately 10 million 9-liter cases worldwide. It is a genuine Russian vodka with international recognition, noting dynamic growth of export.

Zubrowka Bison Grass Vodka is CEDC’s flagship export brand in Poland. It is a vodka with over 600-years of tradition and a unique flavor derived from “bison grass,” an aromatic plant from Poland’s cleanest region of Podlasie. Zubrowka is sold throughout the world in over 50 countries and is a leading imported vodka brand in France, Japan and the UK. The brand sold approx.1 million 9l cases globally in 2010.

Kauffman Vodka is a super premium vodka brand and the first vintage vodka in the world.

“We are pleased to enter into partnership with the strongest distributor in the UK, with great experience in building premium brands in the market. We believe First Drinks Brands will contribute to further expansion of Green Mark which as an authentic, high quality vodka from Russia has great sales potential in the UK, where vodka is the largest spirits category.” – said William Carey, President and CEO of CEDC and continued – “We have been very successful in expanding Green Mark’s export in 2011, winning 7% market share in Ukraine and we will continue to build this brand’s international presence. We also look forward to strengthening the position of Zubrowka which is our key export brand and has already won recognition in the UK market.”

Chris Mason, Managing Director of First Drinks, comments: “We are delighted to be working with CEDC, one of the world’s leading vodka producers and look forward to a long term partnership to achieve our ambitious, mutual goals. The new vodkas are an excellent fit within our existing portfolio, complementing our current brands. We have a strong track record of building premium brands and have big ambitions for 2012 to be in the position to offer our customers the most desired portfolio of authentic vodka brands of any UK distributor.”
“As industry leaders in the UK premium spirits market, our strategy is to build on our reputation as premium brand builders and have a full range of authentic vodkas relevant to both the on and off-trade,” concludes Mason.

CEDC represents William Grant & Sons’ portfolio in Poland and Hungary, including Grant’s Glenfiddich and Balvenie Scotch whisky, Hendrick’s Gin and Tullamore Dew Irish whiskey. CEDC has been present in the UK market with its Zubrowka , Soplica and Graduate brands. First Drinks Brands will be distributing Green Mark and Kauffman Vodka starting from 1st quarter of 2012 and Zubrowka starting from 2nd half of 2012.

About CEDC
CEDC is one of the largest producers of vodka in the world and Central and Eastern Europe’s largest integrated spirit beverage business. CEDC produces the Green Mark, Absolwent, Zubrowka , Bols, Parliament, Zhuravli, Royal and Soplica brands, among others. CEDC currently exports its products to many markets around the world, including the United States, England, France, Japan and Germany.

CEDC also is a leading importer of alcoholic beverages in Poland, Russia and Hungary. In Poland, CEDC imports many of the world’s leading brands, including Carlo Rossi Wines, Concha y Toro wines, Metaxa Liqueur, Remy Martin Cognac, Sutter Home wines, Grant’s Whisky, Jagermeister, E&J Gallo, Jim Beam Bourbon, Sierra Tequila, Teacher’s Whisky, Campari, Cinzano and Old Smuggler. CEDC is also a leading importer of premium spirits and wines in Russia with such brands as Concha y Toro, among others.

Forward Looking Statements

This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward looking statements are based on our knowledge of facts as of the date hereof and involve known and unknown risks and uncertainties that may cause the actual results, performance or achievements of CEDC to be materially different from any future results, performance or achievements expressed or implied by our forward looking statements.

Investors are cautioned that forward looking statements are not guarantees of future performance and that undue reliance should not be placed on such statements. CEDC undertakes no obligation to publicly update or revise any forward looking statements or to make any other forward looking statements, whether as a result of new information, future events or otherwise, unless required to do so by securities laws. Investors are referred to the risks and uncertainties discussed in CEDC’s Form 10-K for the fiscal year ended December 31, 2010, including those under the caption “Item 1A. Risk Factors,” and in other documents filed by CEDC with the Securities and Exchange Commission.

Contact:
Anna Zaluska
Corporate PR Manager
Central European Distribution Corporation
48-22-456-6061

SOURCE Central European Distribution Corporation

Cardium (CXM) Presents New Generx Findings at 2012 Annual Gene and Cell Therapy Forum

L&L (LLEN) Enters Agreement Acquiring Majority Stake of the Weishe Mine

SEATTLE, Jan. 30, 2012 /PRNewswire/ — L & L Energy, Inc., (Nasdaq: LLEN) (“L&L” or the “Company”), a U.S.-based company founded in 1995 with coal mining and distribution businesses in China, announced today that it has entered an agreement acquiring 51% controlling interest of the Weishe coal mine (“The Mine” or “Weishe”) in China.

Weishe Mine Acquisition Highlights

• Purchase Price: Approximately $16.2 million, to be paid in full with 3 million LLEN shares at $5.396/share
• Interest %: 51% controlling interest
• Mine Reserves: 19 million tons in a 1.8 square KM site
• Design: 450,000 ton annually

Estimated FY2013 (Ended April 30) Impact of Weishe

• Production: 124,000 tons
• Price per ton: $158
• Revenues: $19.6 million
• EBITA: $9.8 million
• Cash flow attributable to L&L: $3.75 million

Weishe mine produces high quality, low sulfur, anthracite coal, and is one of three newly constructed mines owned by Union Energy located in Hezhang, Guizhou Province, China. The mine is expected to be expanded to its designed 450,000 tons of annual production over the next few years.

Dr. Syd Peng, L&L board member and world-renown mine expert, said, “I welcome the new Weishe mine, which is the first of many new mines we are targeting to upgrade our mining portfolio for better safety and mechanization.” Mr. Po Shui, owner of Union Energy, a local Guizhou company, stated, “I believe in L&L and am pleased to take common shares as payment. I also look forward to the possibility of joint venturing with L&L on two other Union Energy mines, one of which is scheduled to begin producing in the spring and the other in the fall of this year.”

Dickson Lee, Chairman and CEO of L&L Energy commented, “L&L Energy has been focused on executing our plan for the Guizhou consolidation. With the recently established Hong Gou operational office in Guizhou, the government’s approval of our new wholesales license, and now the addition of the Weishe Mine, we are positioning ourselves well to fully execute the two one millions ton wholesale agreements negotiated in the fall of 2011,” Lee continued. “The management team at the Weishe mine is very strong and will be excellent addition to L&L as we scale at a faster pace. To share in our excitement, we invite investors to visit our new operations this summer.”

Forward-Looking Statements

The statements contained words that are not historical fact, including statements related to Company’s future performance, are all “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and involve a number of risks and uncertainties. Actual results of the future events described in this document could differ materially due to numerous factors and other made by the company filing with the Securities and Exchange Commission. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Contacts:
L&L Energy, Inc.
(206) 264-8065
ir@llenergyinc.com

SoundBite Communications Announces Preliminary Fourth Quarter and Year End 2011 Financial Results

BEDFORD, Mass., Jan. 30, 2012 (GLOBE NEWSWIRE) — SoundBite Communications Inc. (Nasdaq:SDBT), a leading global provider of mobile marketing and contact center solutions, today announced preliminary unaudited financial results for the fourth quarter and the year ended December 31, 2011.

Based on currently available information, the Company expects to report fourth quarter revenue, computed in accordance with U.S. generally accepted accounting principles (GAAP), of at least $11.8 million, the highest revenue quarter in the Company’s history. This compares to the previously guided range of $11.0 million to $11.5 million for the fourth quarter of 2011, and $10.1 million in the year ago period. GAAP operating income for the fourth quarter of 2011 is expected to have been at least $200,000, compared to $50,000 in the year ago period.

In addition, the Company anticipates non-GAAP operating income to have been at least $800,000, exceeding the Company’s previously guided range of $100,000 to $400,000. In computing the preliminary non-GAAP operating income for the fourth quarter, the Company excluded the following estimated amounts: stock based compensation of $300,000 and amortization of intangibles of $300,000 related to the acquisition of SmartReply.

On a full year basis, the Company anticipates revenues of at least $41.5 million, a 5% increase over 2010. The GAAP operating loss is expected to be approximately $2.0 million, compared to $3.3 million in 2010.

“We are very pleased with these preliminary unaudited results.” stated Jim Milton, president and CEO of SoundBite Communications. “SoundBite’s record performance in the fourth quarter was driven by growth in its mobile marketing solutions during a key quarter for Retail, and strength across the entire hosted contact center business.”

Fourth Quarter and Full Year Financial Results

The anticipated results in this press release are based on management’s preliminary analysis of revenue and GAAP Operating Income for the quarter ended December 31, 2011. The Company will release and discuss its fourth quarter and full year 2011 financial results on Wednesday, February 22, 2012 at 5:00 p.m. ET.

Non-GAAP Measures

To supplement its statements of operations information presented in accordance with GAAP, SoundBite uses non-GAAP measures for operating income. In order for investors to be better able to compare its current results with those of previous periods, SoundBite has shown a reconciliation of GAAP to non-GAAP operating income. SoundBite believes the presentation of this non-GAAP financial measure enhances investors’ overall understanding of SoundBite’s historical financial performance. The presentation of non-GAAP operating income is not meant to be considered in isolation or as a substitute for SoundBite’s financial results prepared in accordance with GAAP and SoundBite’s non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

About SoundBite Communications

SoundBite Communications, a leading cloud communications provider, enables organizations to build lifelong, profitable customer relationships via proactive communications across the full consumer lifecycle. We serve two global markets, the Hosted Contact Center and Mobile Marketing. Our solutions leverage the power of two robust platforms: SoundBite Engage, an interactive multi-channel communications platform providing integrated SMS, dialer, voice messaging, email and web communications; and SoundBite Insight, a preference management platform enabling intelligent, personalized communications. SoundBite powers nearly 2 billion customer interactions annually. Visit SoundBite.com for more information.

The SoundBite Communications, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4393

Forward-Looking Statement

This is a “safe harbor” statement under the Private Securities Litigation Reform Act of 1995. The statements regarding operating results for the fourth quarter of 2011 contained in the second through fifth paragraphs of this press release are forward looking and are based upon SoundBite’s historical performance and its current plans, estimates and expectations. The inclusion of this forward-looking information should not be regarded as a representation by SoundBite, its management or any other person that the future plans, estimates or expectations contemplated by SoundBite will be achieved. These forward-looking statements represent SoundBite’s expectations as of the date of this press release. Subsequent events may cause these expectations to change and SoundBite disclaims any obligation to update the forward-looking statements in the future. Matters subject to forward-looking statements involve known and unknown risks and uncertainties, including: slower than anticipated development of the market for automated voice messaging services; defects in SoundBite’s platform; disruptions in its service or errors in its execution; discontinued or decreased use of SoundBite’s service by its clients, which are not subject to minimum purchase requirements for any reason, including market conditions and regulatory developments; and the occurrence of events adversely affecting the collection agencies industry or in-house collection departments, which account for a significant portion of SoundBite’s revenues. These and other factors, including the factors set forth under the caption “Item 1A. Risk Factors” of Part I in SoundBite’s most recent quarterly report on Form 10-Q filed with the Securities and Exchange Commission, could cause SoundBite’s performance or achievements to be materially different from those expressed or implied by the forward-looking statements.

SoundBite is a registered service mark of SoundBite Communications, Inc.

(SDBT-F,G)

CONTACT: Investor Contacts:

         Lynn Ricci
         SoundBite Communications
         +1 781 897 2696
         lricci@SoundBite.com

OTI (OTIV) Receives an Initial $6.9 Million Contract to Supply Electronic Immigration Control System in Panama

ISELIN, N.J., Jan. 30, 2012 (GLOBE NEWSWIRE) — On Track Innovations Ltd. (“OTI”) (Nasdaq:OTIV) today announced that the Ministry of Public Security of Panama has awarded OTI with a contract for the supply, design, installation and integration of systems to monitor and improve immigration verification processes and overall immigration flow. OTI expects to recognize revenues of approximately $6.9 million, with the potential for additional revenue in future years from follow-on contracts.

The contract provides for the supply of OTI’s end-to-end turnkey immigration solution, based on its proprietary state-of-the-art, field-proven eID Magna™ platform. The solution includes data enrollment and issuing stations, as well as individual means to verify identity tied to Biometric Automatic Fingerprint Identification System (AFIS), allowing for better control at border points and increased efficiencies.

Oded Bashan, Chairman and CEO of OTI, stated, “”OTI’s secure ID offerings provide a cost effective, secure and timely to-market solution that leverages and interfaces with legacy systems and records.”

Mr. Bashan continued: “We are happy to expand our footprint in Latin America to support Panama’s efforts to improve identity verification at their borders. By deploying our solution, Panama is taking firm control of immigration security and identity to diminish the substantial risks and costs of illegal immigration and identity theft.”

OTI’s Magna modular platform enables short implementation time frames, seamless integration with a country’s existing border control system and provides external interfaces to a digital Certificate Authority for signature verification. The system is compliant with International Civil Aviation Organization (ICAO) standards and offers a migration path to additional e-Gov applications and electronic ID documents such as National IDs, Voter IDs and Driver Licenses, and more.

The technology and integration within the OTI system enables a much more efficient and secure border control process that should reduce paperwork, operating costs and personnel needs while also substantially streamlining and speeding the immigration process to the satisfaction of all visitors.

About On Track Innovations Ltd. (www.otiglobal.com)

On Track Innovations Ltd. (“OTI”) designs, develops and markets secure identification, payment and transaction processing technologies and solutions for use in secure ID, payment and loyalty applications based on its extensive patent and IP portfolio. OTI combines state-of-the-art, contactless microprocessor-based technologies and enabling hardware with proprietary software applications to deliver high performance, end-to-end solutions that are secure, robust and scalable. OTI solutions have been deployed around the world to address homeland security, national ID, medical ID, contactless payment and NFC (Near Field Communication) with loyalty applications, petroleum payment, parking and mass transit ticketing. OTI markets and supports its solutions through a global network of regional offices and alliances.

The On Track Innovations Ltd. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5736

Safe Harbor for Forward-Looking Statements:

This press release may contain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Whenever we use words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions, we are making forward-looking statements. Because such statements deal with future events and are based on OTI’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of OTI could differ materially from those described in or implied by the statements in this press release. For example, forward-looking statements include statements regarding our goals, beliefs, future growth strategies, objectives, plans or current expectations, such as those regarding the superiority or uniqueness of our products. Forward-looking statements could be impacted by market acceptance of new and existing products and our ability to execute production on orders, as well as the other risk factors discussed in OTI’s Annual Report on Form 20-F for the year ended December 31, 2010, which is on file with the Securities and Exchange Commission. Although OTI believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be achieved. Except as otherwise required by law, OTI disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date hereof, whether as a result of new information, future events or circumstances or otherwise.

The content of websites or website links mentioned or provided herein are not part of this press release.

CONTACT: OTI Contacts:
         Galit Mendelson
         VP, Corporate Relations
         732 429 1900 ext. 111
         galit@otiglobal.com

         Jay M. Meier
         SVP, Business Development & Investor Relations,
         OTI America, Inc.
         732 429 1900 ext. 104
         jaym@otiglobal.com

         Investor Relations:
         Norberto Aja/David Collins
         Jaffoni & Collins
         212-835-8500
         otiv@jcir.com

Popular, Inc. (BPOP) Reports Net Income of $151.3 million for the Year and $3.0 million for the Quarter ended December 31, 2011